Erythropoietin regulates intestinal iron absorption in a rat model of chronic renal failure

Kidney International

Volumn 78, Issue 7, 2010, Pages 660-667

  Srai, Surjit K ^a   Chung, Bomee ^b   Marks, Joanne ^a   Pourvali, Katayoun ^b   Solanky, Nita ^a   Rapisarda, Chiara ^b   Chaston, Timothy B ^a,b   Hanif, Rumeza ^a   Unwin, Robert J ^a   Debnam, Edward S ^a   Sharp, Paul A ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

duodenum; enterocyte; erythropoietin; hepcidin; iron

Indexed keywords

HEPCIDIN; IRON; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHRONIC KIDNEY FAILURE; DRUG MECHANISM; INTESTINE ABSORPTION; INTESTINE CELL; IRON ABSORPTION; IRON TRANSPORT; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 77956878819     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.217     Document Type: Article

References (50)

1. World Health Organization. Maternal Health and Safe Motherhood Programme. The Prevalence of Anaemia in Women: A Tabulation of Available Information, 2nd edn. World Health Organization: Geneva, Switzerland, 1992.
2. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023.
3. Smith MW, Debnam ES, Dashwood MR et al. Structural and cellular adaptation of duodenal iron uptake in rats maintained on an iron-deficient diet. Pflugers Arch 2000; 439: 449-454.
4. Frazer DM, Wilkins SJ, Becker EM et al. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 2002; 123: 835-844.
5. O'Riordan DK, Debnam ES, Sharp PA et al. Mechanisms involved in increased iron uptake across rat duodenal brush-border membrane during hypoxia. J Physiol 1997; 500(Pt 2): 379-384.
6. O'Riordan DK, Sharp P, Sykes RM et al. Cellular mechanisms underlying the increased duodenal iron absorption in rats in response to phenylhydrazine- induced haemolytic anaemia. Eur J Clin Invest 1995; 25: 722-727.
7. Frazer DM, Inglis HR, Wilkins SJ et al. Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut 2004; 53: 1509-1515.
8. Wang GL, Semenza GL. Molecular basis of hypoxia-induced erythropoietin expression. Curr Opin Hematol 1996; 3: 156-162.
9. Bray GL, Taylor B, O'Donnell R. Comparison of the erythropoietin response in children with aplastic anemia, transient erythroblastopenia, and iron deficiency. J Pediatr 1992; 120(4 Pt 1): 528-532.
10. Joosten E, Van HL, Lesaffre E et al. Serum erythropoietin levels in elderly inpatients with anemia of chronic disorders and iron deficiency anemia. J Am Geriatr Soc 1993; 41: 1301-1304.
11. Johnson CA, Chester MI. Pathophysiology and treatment of the anemia of renal failure. Clin Pharm 1988; 7: 117-122.
12. Macdougall IC, Tucker B, Thompson J et al. A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 1996; 50: 1694-1699.
13. Nicolas G, Viatte L, Bennoun M et al. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 2002; 29: 327-335.
14. Pinto JP, Ribeiro S, Pontes H et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood 2008; 111: 5727-5733.
15. Kong WN, Chang YZ, Wang SM et al. Effect of erythropoietin on hepcidin, DMT1 with IRE, and hephaestin gene expression in duodenum of rats. J Gastroenterol 2008; 43: 136-143.
16. Huang H, Constante M, Layoun A et al. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 2009; 113: 3593-3599.
17. Vokurka M, Krijt J, Sulc K et al. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 2006; 55: 667-674.
18. Pak M, Lopez MA, Gabayan V et al. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006; 108: 3730-3735.
19. Knutson MD, Oukka M, Koss LM et al. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci USA 2005; 102: 1324-1328.
20. Delaby C, Pilard N, Goncalves AS et al. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood 2005; 106: 3979-3984.
21. Chaston T, Chung B, Mascarenhas M et al. Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut 2008; 57: 374-382.
22. Laftah AH, Ramesh B, Simpson RJ et al. Effect of hepcidin on intestinal iron absorption in mice. Blood 2004; 103: 3940-3944.
23. Yamaji S, Sharp P, Ramesh B et al. Inhibition of iron transport across human intestinal epithelial cells by hepcidin. Blood 2004; 104: 2178-2180.
24. Mena NP, Esparza A, Tapia V et al. Hepcidin inhibits apical iron uptake in intestinal cells. Am J Physiol Gastrointest Liver Physiol 2008; 294: G192-G198.
25. Chung B, Chaston T, Marks J et al. Hepcidin decreases iron transporter expression in vivo in mouse duodenum and spleen and in vitro in THP-1 macrophages and intestinal Caco-2 cells. J Nutr 2009; 139: 1457-1462.
26. Ashby DR, Gale DP, Busbridge M et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int 2009; 75: 976-981.
27. Sharp P, Srai SK. Molecular mechanisms involved in intestinal iron absorption. World J Gastroenterol 2007; 13: 4716-4724.
28. Tandy S, Williams M, Leggett A et al. Nramp2 expression is associated with pH-dependent iron uptake across the apical membrane of human intestinal Caco-2 cells. J Biol Chem 2000; 275: 1023-1029.
29. Witthuhn BA, Quelle FW, Silvennoinen O et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993; 74: 227-236.
30. Bittorf T, Jaster R, Ludtke B et al. Requirement for JAK2 in erythropoietin-induced signalling pathways. Cell Signal 1997; 9: 85-89.
31. Cavill I. Iron and erythropoietin in renal disease. Nephrol Dial Transplant 2002; 17(Suppl 5): 19-23.
32. Zager RA, Johnson AC, Hanson SY. Parenteral iron nephrotoxicity: potential mechanisms and consequences. Kidney Int 2004; 66: 144-156.
33. Kuo KL, Hung SC, Wei YH et al. Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. J Am Soc Nephrol 2008; 19: 1817-1826.
34. Ganz T, Olbina G, Girelli D et al. Immunoassay for human serum hepcidin. Blood 2008; 112: 4292-4297.
35. Tomosugi N, Kawabata H, Wakatabe R et al. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood 2006; 108: 1381-1387.
36. Nicolas G, Chauvet C, Viatte L et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002; 110: 1037-1044.
37. Nemeth E, Valore EV, Territo M et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003; 101: 2461-2463.
38. Nemeth E, Rivera S, Gabayan V et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-1276.
39. Rivera S, Nemeth E, Gabayan V et al. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 2005; 106: 2196-2199.
40. Johnson D, Bayele H, Johnston K et al. Tumour necrosis factor alpha regulates iron transport and transporter expression in human intestinal epithelial cells. FEBS Lett 2004; 573: 195-201.
41. Sharma N, Laftah AH, Brookes MJ et al. A role for tumour necrosis factor alpha in human small bowel iron transport. Biochem J 2005; 390(Pt 2): 437-446.
42. Laftah AH, Sharma N, Brookes MJ et al. Tumour necrosis factor alpha causes hypoferraemia and reduced intestinal iron absorption in mice. Biochem J 2006; 397: 61-67.
43. Juul SE, Joyce AE, Zhao Y et al. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res 1999; 46: 263-268.
44. Juul SE, Ledbetter DJ, Joyce AE et al. Erythropoietin acts as a trophic factor in neonatal rat intestine. Gut 2001; 49: 182-189.
45. Skikne BS, Cook JD. Effect of enhanced erythropoiesis on iron absorption. J Lab Clin Med 1992; 120: 746-751.
46. Sharp P. Methods and options for estimating iron and zinc bioavailability using Caco-2 cell models: benefits and limitations. Int J Vitam Nutr Res 2005; 75: 413-421.
47. Latunde-Dada GO, Simpson RJ, McKie AT. Duodenal cytochrome B expression stimulates iron uptake by human intestinal epithelial cells. J Nutr 2008; 138: 991-995.
48. Marks J, Churchill LJ, Srai SK et al. Intestinal phosphate absorption in a model of chronic renal failure. Kidney Int 2007; 72: 166-173.
49. Johnson DM, Yamaji S, Tennant J et al. Regulation of divalent metal transporter expression in human intestinal epithelial cells following exposure to non-haem iron. FEBS Lett 2005; 579: 1923-1929.
50. Williams M, Sharp P. Regulation of jejunal glucose transporter expression by forskolin. Biochim Biophys Acta 2002; 1559: 179-185.